Ubs Group Ag Zoetis Inc. Call Options Transaction History

Ubs Group Ag

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$172.58 - $196.48 $4.66 Million - $5.3 Million	-27,000 Reduced 71.05%	11,000 $2.15 Million
Q2 2024 Aug 13, 2024	BUY	$145.54 - $178.83 $5.53 Million - $6.8 Million	38,000 New	38,000 $6.59 Million
Q4 2022 Feb 08, 2023	BUY	$131.14 - $157.47 $3.84 Million - $4.61 Million	29,300 New	29,300 $4.3 Million
Q3 2019 Nov 14, 2019	BUY	$112.57 - $128.43 $4.31 Million - $4.92 Million	38,300 Added 327.35%	50,000 $6.23 Million
Q4 2017 Feb 14, 2018	BUY	$63.24 - $72.8 $739,908 - $851,760	11,700	11,700 $843,000

1,957

410M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $76.1B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.